# Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder

> **NCT02659085** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pouya Movahed Rad** · enrollment: 198 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Ketamine IV Infusion
- **PROCEDURE:** ECT

## Key facts

- **NCT ID:** NCT02659085
- **Lead sponsor:** Pouya Movahed Rad
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2019-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02659085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02659085, "Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02659085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*